Endocrine Abstracts

Contents

• 45th Annual Meeting of the European Thyroid Association ETA 2023
• • Oral Session 1: Highlights in Thyroidology: in Memory of Jacques Dumont
  • • Patient-Derived medullary thyroid cancer organoids; a model for patient-tailored drug and tracer screening

      ea0092op-01-01
    • Long-Term outcomes of active surveillance for low-risk papillary thyroid carcinoma: is lifelong follow-up necessary?

      ea0092op-01-02
    • Circulating MIR-146A and MIR-21 predict glucocorticoid response in thyroid eye disease

      ea0092op-01-03
    • Should hypothyroxinaemia during early gestation be regarded as a condition of oxidative stress?

      ea0092op-01-04
    • RNA guanine-quadruplexes as novel regulators of translation and alternative splicing of tr alpha isoforms

      ea0092op-01-05
    • Phenotypic differences in resistance to thyroid hormone alpha: differential recruitment of cofactors by thyroid hormone receptor alpha 1 mutants

      ea0092op-01-06
  • Oral Session 2: Thyroid hormone action in the brain
  • • Impact of thyroid hormone transport on hippocampal gabaergic and glutamatergic systems in the mouse CNS

      ea0092op-02-01
    • Development of an image-based method for spatial registration of T3-induced changes in cell types and gene expression in human cerebral organoids

      ea0092op-02-02
    • Effects of maternal administration of TH-Analog sobetirome and its CNS-Selective prodrug SOB-AM2 in murine MCT8-deficient fetuses

      ea0092op-02-03
    • Unravelling the effects of the effect of mutant thrsz in cortical neuron differentiation

      ea0092op-02-04
    • MCT8 expression changes under pathophysiological conditions in the adult human brain

      ea0092op-02-05
  • Oral Session 3: Signalling in Thyroid cancer
  • • Patient-Derived in vitro models for unraveling medullary thyroid cancer microenvironment and therapy resistance

      ea0092op-03-01
    • Determination of the role of map kinase and PI3K/AKT signaling pathways in the regulation of multidrug resistance proteins in thyroid cancer

      ea0092op-03-02
    • Involvement of mapk-scaffold proteins iqgap in thyroid cancer

      ea0092op-03-03
    • Exploring the potential of siglec15 as novel immunotherapeutic target in (thyroid) cancer: focus on innate immune cells

      ea0092op-03-04
    • From nucleus to mitochondria: insights into the role of tert in aggressive papillary thyroid carcinomas

      ea0092op-03-05
  • Oral Session 4: Young Investigators / Clinical and Translational
  • • Interaction between DIO2 polymorphisms and LT4 treatment on psychological well-being outcomes and cardiovascular risk factors: a population-based cross-sectional study in uk biobank

      ea0092op-04-01
    • Teprotumumab-Related adverse events in thyroid eye disease: a multi-center real world study

      ea0092op-04-02
    • Long-Term outcome of the thyroid function in graves' disease: a nationwide danish register study

      ea0092op-04-03
    • The association between maternal thyroid function and language acquisition in offspring aged 12 to 37 months: an odense child cohort study

      ea0092op-04-04
    • Active surveillance: a feasible option for indeterminate thyroid nodules

      ea0092op-04-05
    • Cardiac function during early treatment for differentiated thyroid carcinoma

      ea0092op-04-06
  • Oral Session 5: Young Investigators / Basic
  • • Development and successful treatment of a novel mouse model for anaplastic thyroid cancer

      ea0092op-05-01
    • Thyroid tumor microenvironment: deconvolution of tumor composition using DNA methylation data

      ea0092op-05-02
    • The role of thyroid hormone transporters in macrophage function

      ea0092op-05-03
    • Multi-Trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications

      ea0092op-05-04
    • Distinguishing beneficial local from adverse systemic thyroid hormone action in alcoholic liver disease

      ea0092op-05-05
    • A minimally invasive human biomarker system for the estimation of tissue thyroid hormone status and its application in amiodarone treated patients

      ea0092op-05-06
  • Oral Session 6: Pregnancy
  • • Antithyroid drug exposure during 1,191,904 pregnancies in denmark: a 20-year longitudinal study before and after implementation of iodine fortification

      ea0092op-06-01
    • Optimizing the dutch newborn screening for congenital hyothyroidism by using amino acids and acylcarnitines via a machine learning based approach

      ea0092op-06-02
    • Thyroid function in childhood is associated with sex, age, bmi, maternal thyroid function, pax8 gene methylation

      ea0092op-06-03
    • Changes in TSH suppression during pregnancy reveals novel mechanism for increased thyroid hormone production: comparison between euthyroid and thyroidectomized pregnant women

      ea0092op-06-04
    • The association of gestational thyroid function with gestational diabetes mellitus: an individual participant meta-analysis

      ea0092op-06-05
  • Oral Session 7: Thyroid hormone receptors
  • • Monocyte and macrophage function is impaired in patients with resistance to thyroid hormone due to a mutation in thyroid hormone receptor ALPHA

      ea0092op-07-01
    • Tanycytic thyroid hormone signalling in the regulation of hypothalamic functions and hormone uptake

      ea0092op-07-02
    • Rapid screening of thra variants pathogenicity in the zebrafish model

      ea0092op-07-03
    • Characterizing cell-type specific activities of tralpha2 in the modulation of thyroid hormone action

      ea0092op-07-04
    • Thyroid hormone action in chronic ischemic heart disease

      ea0092op-07-05
  • Oral Session 8: Hypothyrodism / Nodules
  • • Evaluation of learning methods similar to deep learning and device using deep learning for the diagnosis of thyroid nodules

      ea0092op-08-01
    • Individuals on levothyroxine have higher hads anxiety and depression scores than the general population and this is exacerbated by the THR92ALA substitution in DIO2, particularly at higher doses

      ea0092op-08-02
    • Diagnostic performance of ultrasound-based risk stratification systems for thyroid nodules: a systematic review and meta-analysis

      ea0092op-08-03
    • Testing for a causal role of thyroid hormone measurements within the normal range: a systematic mendelian randomization study

      ea0092op-08-04
    • Thyroid hormone profiles in individuals on non standard thyroid hormone replacement

      ea0092op-08-05
  • Oral Session 9: Thyroid Eye Disease
  • • VRDN-001, a full antagonist antibody to IGF-1 receptor: in vitro pharmacology and phase 1/2 results in patients with thyroid eye disease (TED)

      ea0092op-09-01
    • Preclinical pharmacokinetics and clinical exposure prediction for VRDN-003, a next-generation half-life extended antibody to the IGF-1 receptor for thyroid eye disease

      ea0092op-09-02
    • Linsitinib, AN IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease

      ea0092op-09-03
    • Novel, rapid, sensitive bioassay for thyrotropin receptor stimulatory antibodies- a multicenter, single blind study

      ea0092op-09-04
    • Clinical and visual outcomes of dysthyroid optic neuropathy after surgical orbital decompression

      ea0092op-09-05
  • Oral Session 10: Novel diagnostics in Thyroid cancer
  • • Identification of clinical and histopathological risk factors for radioactive iodine refractory disease in patients with follicular and hurthle cell thyroid carcinoma

      ea0092op-10-01
    • Role of the telomere abnormalities and chromosome fragility on the risk of second malignant tumor in papillary thyroid cancer patients

      ea0092op-10-02
    • KI67 proliferative index, but not mitotic count and necrosis, is a prognostic factor in patients with medullary thyroid cancer: a single-center retrospective analysis according to the 2022 who pathological classification

      ea0092op-10-03
    • Improvement in neck ultrasound report quality following implementation of ETA guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study

      ea0092op-10-04
    • Hypothyroidism and the risk of cancer: a danish register-based long-term follow-up study

      ea0092op-10-05
  • Oral Session 11: Autoimmunity / Hyperthyroidism
  • • Effect of gluten-free diet on autoimmune thyroiditis progression in patients with no histological confirm of celiac disease: a meta-analisys

      ea0092op-11-01
    • Systematic assessment of polyautoimmunity in patients with established lymphocytic thyroiditis

      ea0092op-11-02
    • Effects of acute triiodothyronine treatment in patients with anterior myocardial infarction undergoing primary angioplasty: does infarct size matter?

      ea0092op-11-03
    • Comparison of long-term mortality and cardiometabolic effects of treatment for hyperthyroidism: egret study

      ea0092op-11-04
    • Association between thyroid function and osteoarthritis: a population-based cohort study

      ea0092op-11-05
  • Oral Session 12: Emerging Insights into Thyroid Cancer Genetics
  • • Prospective evaluation of thyrospec molecular testing of indeterminate thyroid nodule cytologies following diagnostic pathway optimization

      ea0092op-12-01
    • Comparative analysis of somatic copy number alterations (SCNA) between hurthle cell tumors (HCT) and oncocytic variant of follicular cell derived thyroid tumors (OV-FCDTT)

      ea0092op-12-02
    • Different histological variants in multifocal PTC analyzed by NGS show an independent molecular origin

      ea0092op-12-03
    • Genetics of familial non-medullary thyroid carcinoma - investigation of two families'

      ea0092op-12-04
    • Braf fusion genes in a large cohort of thyroid carcinomas

      ea0092op-12-05
  • Oral Session 13: Pathophysiological actions of thyroid hormones
  • • Deiodinase type 3 depletion in fibroadipogenic progenitors improves regeneration of dystrophic muscle

      ea0092op-13-01
    • Induced types 2 and 3 deiodinase in the muscle of critically ill patients correlates with endoplasmic reticulum and mitochondria alterations: Implications to nonthyroidal illness syndrome pathophysiology

      ea0092op-13-02
    • Thyroid hormone signalling regulates beta-cell pathological growth, dedifferentiation and transdifferentiation in diabetic pancreas

      ea0092op-13-03
    • Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors

      ea0092op-13-04
    • Thyroid hormone action in acetaminophen-induced acute liver failure

      ea0092op-13-05
• Poster Presentations
• • Cancer
  • • Impact of the 3rd edition of bethesda system for reporting thyroid cytopathology on grey zone categories

      ea0092ps1-01-01
    • Serum potassium in thyroid cancer patients undergoing thyroid hormone withdrawal prior to radioactive iodine treatment: a retrospective study at a single institution

      ea0092ps1-01-02
    • Efficacy and safety of radiofrequency ablation in active surveillance candidate for low-risk papillary thyroid microcarcinoma

      ea0092ps1-01-03
    • Papillary thyroid carcinoma from a thyroglossal duct cyst: a rare association

      ea0092ps1-01-04
    • Radioiodine therapy for thyroid cancer and dyfunction of the salivary and lachrymal glands in the start study: results at 6 months follow-up

      ea0092ps1-01-05
    • Morphometric analysis of lateral cervical lymph node metastasis in papillary thyroid carcinoma using digital pathology

      ea0092ps1-01-06
    • Type 2 diabetes and obesity are not likely to be risk factors for thyroid cancer

      ea0092ps1-01-07
    • Significance of bilaterality and multifocality in papillary thyroid cancer

      ea0092ps1-01-08
    • Risk of renal adverse effects in patients with advanced thyroid cancer who are undergoing radiological monitoring, with a particular focus on patients receiving tyrosine kinase inhibitors

      ea0092ps1-01-09
    • Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib

      ea0092ps1-01-10
  • Graves’ Disease
  • • Preoperative management of graves' disease: should all patients be euthyroid?

      ea0092ps1-02-01
    • Predetermined vs calculated 131I activity for the treatment of patients with graves' disease: which is the best?

      ea0092ps1-02-02
    • Analysis of cost and treatment effects in the care given for graves disease - a swedish cost-utility analysis

      ea0092ps1-02-03
    • The relationship between mental fatigue, anxiety and depression in graves disease

      ea0092ps1-02-04
    • Association between radioactive iodine treatment and cancer risk in graves' disease: a nationwide cohort study

      ea0092ps1-02-05
    • The role of selenium supplement in graves disease - a case report

      ea0092ps1-02-06
    • Agranulocitosis caused by methimazole in a patient with graves' disease and multiple myeloma

      ea0092ps1-02-07
    • Evaluation of paraoxonase (PON-1) activity and advanced glycation end-products (AGES) as reliable markers of oxidative stress in graves' disease patients

      ea0092ps1-02-08
    • Patients` experience of being affected by graves`disease-the initial 3 month-phase

      ea0092ps1-02-09
  • Miscellaneous 1
  • • Goiter in history, literature, and art

      ea0092ps1-03-01
    • Safety and efficacy of prophylactic treatment for hyperthyroidism induced by iodinated contrast media in a high-risk population

      ea0092ps1-03-02
    • Treatment of obesity with thyroid hormones: data from the thesis* collaboration. *treatment of hypothyroidism in europe by specialists, an international survey

      ea0092ps1-03-03
    • Association between immune-related thyroid dysfunction and the efficacy of immune checkpoint inhibitors

      ea0092ps1-03-04
    • Thyroid dysfunction in head and neck squamous cell carcinoma patients after external radiotherapy: clinicopathological risk factors

      ea0092ps1-03-05
    • The importance of determining the PTH level in the early phase of the assessment in elderly patients to exclude the early phase of hyperparathyroidism

      ea0092ps1-03-06
    • Obesity and metabolic parameters are not dependent on TSH levels within normal range in young women with autoimmune thyroiditis on levothyroxine therapy

      ea0092ps1-03-07
    • The prevalence and characteristics of immune checkpoint inhibitors induced thyroid adverse events in korea: a nationwide cohort study, 2017-2020

      ea0092ps1-03-08
    • Iodine nutrition in greenland: urinary iodine concentration during a 20-year period

      ea0092ps1-03-09
  • Nodules-surgery
  • • Individualized approach to the patients with autonomously functioning thyroid nodules and normal TSH blood level

      ea0092ps1-04-01
    • Early voice problems assessment in post-thyroidectomy syndrome using vocal fatigue index and cepstral analysis

      ea0092ps1-04-02
    • Elastographic evaluation of thyroid nodules in children and adolescents with hashimoto's thyroiditis and nodular goiter with reference to cytological/histopathological diagnosis

      ea0092ps1-04-03
    • Volume reduction rate's predictors after radiofrequency ablation of benign thyroid nodules. a single-centre analysis

      ea0092ps1-04-04
    • Clinical significance of serum thyroglobulin and tumor volume in delayed surgery for thyroid follicular neoplasms

      ea0092ps1-04-05
    • Role of superb microvascular imaging in thyroid nodule risk stratification

      ea0092ps1-04-06
    • Completion thyroidectomy via robotic transoral vestibular approach - preliminary outcome report

      ea0092ps1-04-07
    • Effects of low Vitamin D on calcium and phosphate metabolism and thyroid nodule stiffness

      ea0092ps1-04-08
    • Vocal morbidity related to the external branch of the suprerior laryngeal nerve following thyroidectomy

      ea0092ps1-04-09
  • Thyroid hormone diagnostics 1
  • • Functional thyrotropin receptor autoantibodies in women with thyroid autoimmunity and the impact of ovarian stimulation

      ea0092ps1-05-01
    • Abstract unavailable

      ea0092ps1-05-02
    • Usefulness of real-time quantitative microvascular ultrasonography for differentiation of graves' disease from destructive thyroiditis in thyrotoxic patients: prospective study

      ea0092ps1-05-03
    • Higher titer of thyrotropin binding inhibitor immunoglobulin was associated with higher level of free thyroxine in graves' disease

      ea0092ps1-05-04
    • Multicenter, 5-assay comparison of thyrotropin receptor blocking antibodies

      ea0092ps1-05-05
    • Predictive value of us doppler and microvascular imaging in differentiating benign and malignant thyroid nodules

      ea0092ps1-05-06
    • Real-Time assessment of the beneficial role of artifical intelligence-based computer assisted diagnosis (AI-CAD) of thyroid nodules on ultrasound

      ea0092ps1-05-07
    • The risk of thyroid eye disease is increased following covid-19 vaccination

      ea0092ps1-05-08
    • Dried blood spot thyroglobulin in newborns as a surrogate biomarker for monitoring of iodine status of the population

      ea0092ps1-05-09
  • Thyroid Cancer clinical 1
  • • Components of collaborative thyroid care clinics in the mississauga-halton regions in ontario, canada

      ea0092ps1-06-01
    • Long-Term outcomes following initial therapy in differentiated thyroid cancer (DTC) in china: DTCC 2nd stage study analysis 2014-2022

      ea0092ps1-06-02
    • Clinical and surgical challenges of local relapse of papillary thyroid carcinoma (PTC)

      ea0092ps1-06-03
    • Predictive factors for central neck compartment lymphnodes metastases' in sporadic medullary thyroid cancer patients

      ea0092ps1-06-04
    • Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha & beta testing

      ea0092ps1-06-05
    • Papillary thyroid carcinoma associated with thyroiditis: about a series

      ea0092ps1-06-06
    • Thyroid cancer in ukrainian children during 35 years after the accident at the chernobyl nuclear power plant

      ea0092ps1-06-07
    • Hypertension during lenvatinib for advanced thyroid cancer: a diagnostic and therapeutic algorithm for its management

      ea0092ps1-06-08
    • Four cases of anaplastic thyroid carcinoma

      ea0092ps1-06-09
  • Thyroid Cancer Diagnosis 1
  • • Elevated CRP and leukocytosis at diagnosis, but not elevated ESR, are prognostic markers in anaplastic thyroid cancer

      ea0092ps1-07-01
    • Optimal cut-off values of protrusion angle of tumor on sonography (PATOS) system to predicting extrathyroidal extension in papillary thyroid carcinoma according to location

      ea0092ps1-07-02
    • Comparison in ultrasonography (US) features and the korean-thyroid imaging reporting and DATA system (K-TIRADS) of isthmic and lobar papillary thyroid carcinomas (PTC)

      ea0092ps1-07-03
    • Role of ultrasound in predicting tert promoter mutation in follicular thyroid carcinoma

      ea0092ps1-07-04
    • Ultrasonographic prediction of tumor invasiveness in follicular thyroid carcinoma: based on the who classification and tert promoter mutation

      ea0092ps1-07-05
    • Validation of ct-based risk stratification systems for lymph node metastasis in patients with thyroid cancer

      ea0092ps1-07-06
    • Macrofollicular variant of papillary thyroid carcinoma: ultrasonographic findings and clinical implications

      ea0092ps1-07-07
    • Abstract unavailable

      ea0092ps1-07-08
    • Clinical significance of tumor size in gross extrathyroidal extension to strap muscles(T3B) in papillary thyroid carcinoma

      ea0092ps1-07-09
  • Translational 1
  • • Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI resistant metastatic thyroid cancers

      ea0092ps1-08-01
    • Transcriptomic analysis reveals tumor microenvironment plays important role in nodal metastasis of papillary microcarcinomas

      ea0092ps1-08-02
    • Immunocytochemical staining for HBME-1 expression in the "diagnostic search" of differentiated thyroid cancer

      ea0092ps1-08-03
    • Association between BMI and Brafv600E mutation status may differ by primary tumor size

      ea0092ps1-08-04
    • Can tert promoter mutation be a poor prognostic factor in undifferentiated thyroid carcinoma?

      ea0092ps1-08-05
    • Comparative cyto-histological genetic profile in a series of differentiated thyroid carcinomas

      ea0092ps1-08-06
    • The role of metabolic markers, TYG and TYG-BMI indices in predicting the risk of thyroid cancer

      ea0092ps1-08-07
    • The role of micrornas to the diagnosis of differentiated thyroid carcinomas

      ea0092ps1-08-08
    • Identification of rare braf variants in thyroid nodules

      ea0092ps1-08-09
  • Thyroid Cancer
  • • Thyroid cancer and endocrine disruptive chemicals: a case-control study on per-fluoroalkyl substances (PFAS)

      ea0092ps1-09-01
    • The absence of TSHR-GPER heteromers is a potential marker of thyroid cancer

      ea0092ps1-09-02
    • Prophylactic bilateral central neck dissection does not improve the short term response to surgery and radioiodine ablation in differentiated thyroid cancer

      ea0092ps1-09-03
    • Development and pre-clinical validation of next-generation sequencing gene panel to detect clinically relevant mutations in thyroid cytological and histological samples

      ea0092ps1-09-04
    • Inactivating mutations of TP53 and resistence to tyrosine-kinase inhibitors in patients affected with aggressive thyroid cancer

      ea0092ps1-09-05
    • Targeting the DNA damage response kinase CHK1 in TP53-mutated thyroid cancer: in vitro studies

      ea0092ps1-09-06
    • Familial papillary thyroid carcinoma as a new clinical entity

      ea0092ps1-09-07
    • Overexpression of activated focal adhesion kinase correlates with adverse clinicopathological factors of papillary thyroid carcinoma

      ea0092ps1-09-08
    • A novel somatic genetic alteration in sporadic medullary thyroid carcinoma

      ea0092ps1-09-09
  • Basic Thyroid Gland, Iodine & Autoimmunity Basic
  • • Targeting interleukin-11 signaling, an emerging patholgical mediator in thyroid eye disease

      ea0092ps1-10-01
    • Decreasing iodine intake among pregnant faroese women

      ea0092ps1-10-02
    • Characterization of anti-thyroglobulin antibodies epitopes in patients with hashimoto's thyroiditis in areas with normal and excessive iodine intake

      ea0092ps1-10-03
    • Nutritional iodine status & thyroid homeostasis in pregnant women from iodine-deficient environments in india

      ea0092ps1-10-04
    • A relationship between thyroid disorders and chronic rhinosinusitis: a nested case-control study using national health screening cohort

      ea0092ps1-10-05
    • Reference range of maternal thyroid hormones from rural himalayan foothills (TEHRI CLUSTER): a cross sectional study

      ea0092ps1-10-06
    • Aryl hydrocarbon receptor (AHR) polymorphisms may contribute to the genetic susceptibility to hashimoto's thyroiditis (HT), favouring the onset of the autoimmune disorder when exposed to pullutants

      ea0092ps1-10-07
    • Thyroid-Resident memory T-cells specific for SARS-COV-2 are enriched in patients with thyroid disorders related to covid-19

      ea0092ps1-10-08
    • Analysis of T- and B- lymphocytic infiltrate of target tissues in patients with graves' disease and orbitopathy

      ea0092ps1-10-09
  • Miscellaneous 2
  • • Temporal pattern of thyroid function changes in patients with cured and not cured adrenocorticotropin (ACTH)-Dependent Hypercortisolism

      ea0092ps2-11-01
    • Resistance to thyroid hormone alpha: outcomes of twelve years of thyroxine therapy

      ea0092ps2-11-02
    • Evaluation of advanced end glycation products (AGES), their solube receptors (SRAGE) and the components of oxidative stress in patients with hashimoto's thyroiditis on levothyroxine substitution

      ea0092ps2-11-03
    • Behavior of thyroid function tests in a brazilian elderly population using big data

      ea0092ps2-11-04
    • Sensitivity to thyroid hormones and cardiometabolic risk in euthyroid obese children: A cross-sectional study

      ea0092ps2-11-05
    • Thyroid disorders in the faroe islands: incidence of hyperthyroidism, hypothyroidism, and structural abnormalities

      ea0092ps2-11-06
    • Abstract unavailable

      ea0092ps2-11-07
    • Strange changes in thyroid hormone metabolism in post-covid patients in ajara

      ea0092ps2-11-08
    • Thyroid dysfunctions in covid-19 patients: impact on in-hospital outcomes and long-covid symptoms

      ea0092ps2-11-09
  • Nodules 1
  • • Radiofrequency vesus ethanol ablation for single-session treatment of benign cystic thyroid nodules: a short-term retrospective study

      ea0092ps2-12-01
    • Efficacy and safety of single-session radiofrequency ablation in treating benign thyroid nodules: A short-term prospective study

      ea0092ps2-12-02
    • Malignancy risk stratification and subcategorization of intermediate suspicion thyroid nodules: A retrospective multicenter validation study

      ea0092ps2-12-03
    • Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: What we have to know

      ea0092ps2-12-04
    • Diagnosis of malignany in surgery after rf ablation of benign thyroid nodule

      ea0092ps2-12-05
    • Assessment of an artificial intelligence-based decision support system in the thyroid nodule evaluation in clinical practice

      ea0092ps2-12-06
    • A prospective study on a short course of lugol's solution in toxic nodular goiter

      ea0092ps2-12-07
    • Practice of low risk papillary thyroid cancer treatment: Active surveillance vs immediate surgery

      ea0092ps2-12-08
    • Pediatric patients with goiter and normal thyroid function: US findings related to underlying autoimmune thyroid diseases

      ea0092ps2-12-09
  • Surgery
  • • Does presence of deranged thyroid hormone impact the post-surgery outcomes in the patients undergoing CABG procedure?

      ea0092ps2-13-01
    • Comparison of voice outcome according to the degree of thyroidectomy skin flap

      ea0092ps2-13-02
    • Clinical application of pectoralis nerve block ii for flap dissection-related pain control after robotic transaxillary thyroidectomy: preliminary results of a randomized controlled trial

      ea0092ps2-13-03
    • Multifocality is not a risk factor for recurrence after thyroid lobectomy: A study of 1,684 patients with differentiated thyroid cancer

      ea0092ps2-13-04
    • Survey results comparing transoral thyroidecotmy to open thyroidectomy

      ea0092ps2-13-05
    • Prospective implementation of thyroid lobectomy recommendations and thyrospec molecular testing for bethesda III and IV nodules and impact on surgery

      ea0092ps2-13-06
    • Abstract unavailable

      ea0092ps2-13-07
    • The effect of surgery extent on vocal alteration following thyroidectomy

      ea0092ps2-13-08
    • Body mass index and postoperative morbidity after thyroid surgery: findings from a large retrospective cohort study

      ea0092ps2-13-09
    • Transoral robotic thyroidectomy for thyroid diseases - lessons learned from a 1000 consecutive procedures

      ea0092ps2-13-10
  • Case Reports 1
  • • A case of congenital "hypothyroidism"

      ea0092ps2-14-01
    • Thyrotoxicosis in a patient with turner syndrome: radioactive iodine therapy

      ea0092ps2-14-02
    • Two cases of radioactive iodine refractory malignant struma ovarii with nras mutation

      ea0092ps2-14-03
    • Diagnosis and management of a thyrotoxicosis storm on unknown hyperthyroidism

      ea0092ps2-14-04
    • 28 years of thyroid eye disease reactivations

      ea0092ps2-14-05
    • Amyloid goiter in patient with mediteranian fever

      ea0092ps2-14-06
    • Primary thyroid mucoepidermoid carcinoma with extensive pulmonary metastasis

      ea0092ps2-14-07
    • Thyrotoxic periodic paralysis: report of two cases

      ea0092ps2-14-08
    • Lowering of circulating thyroxine levels in graves' disease resulting in rhabdomyolysis: A less known complication in management of graves' disease

      ea0092ps2-14-09
  • Hyperthyroidism
  • • A prospective, observational study on the effect of an ablative vs a conservative approach for the treatment of graves' hyperthyroidism in patients with moderate-to-severe, active graves' orbitopathy

      ea0092ps2-15-01
    • Grip strength in newly diagnosed hyperthyroidism

      ea0092ps2-15-02
    • Does iodine fortification affect the risk of atrial fibrillation in incident hyperthyroidism?

      ea0092ps2-15-03
    • THY-PRO 39 questionnaire in graves` disease patients after therapy

      ea0092ps2-15-04
    • Resting heart rate monitoring for optimized treatment of hyperthyroidism - the pulsar-study

      ea0092ps2-15-05
    • Factors influencing early outcome of radioiodine treatment in patients with graves' disease

      ea0092ps2-15-06
    • Immunogenetics markers of graves' disease relapse after antithyroid treatment

      ea0092ps2-15-07
    • Extended pharmacometrics computer model utilizes heart rate to monitor thyroid function in adults with graves' disease under carbimazole monotherapy

      ea0092ps2-15-08
    • Long-term follow-up after antithyroid drug treatment withdrawal in patients with the first episode of graves` disease: a retrospective cohort study in spain

      ea0092ps2-15-09
  • Thyroid Cancer clinical 2
  • • Follicular thyroid cancer in lenvatinib therapy complicated by tracheoesophageal fistula treated with pharyngo-laryngo-esophagectomy and definitive tracheostomy

      ea0092ps2-16-01
    • BIG data analysis of secondary cancer risk according to thyroid cancer in patients with lipid metabolic disease

      ea0092ps2-16-02
    • The incidence of thyroid cancer in europe: A meta-analysis

      ea0092ps2-16-03
    • A rare association: graves's disease and thyroid cancer with hyperfunctioning lung metastasis

      ea0092ps2-16-04
    • Quality of life in differentiated thyroid cancer survivors in bulgaria

      ea0092ps2-16-05
    • Prevalence, screening and clinical implications of thyroid cancer in patients with acromegaly: A cohort study

      ea0092ps2-16-06
    • Tumor lysis syndrome during neoadjuvant selpercatinib treatment for medullary thyroid cancer

      ea0092ps2-16-07
    • Lobectomy outcomes in patients with low-risk differentiated thyroid cancer: oncologic and safety outcomes at a swiss tertiary referral center

      ea0092ps2-16-08
    • A rare case of late folliculate of the lower limbs secondary to vandetanib

      ea0092ps2-16-09
  • Thyroid Cancer Diagnosis 2
  • • The 2017 bethesda system for reporting thyroid cytopathology: the experience of a tertiary center

      ea0092ps2-17-01
    • Monocentric validation of the 'thyroid risk score' (TRS) in a large series of indeterminate thyroid nodules

      ea0092ps2-17-02
    • Role of cervical ultrasound in the pre-operative evaluation of central compartment lymph nodes in thyroid cancer

      ea0092ps2-17-03
    • PRO-gastrin-releasing peptide as an additional screening marker in the diagnostic work up for medullary thyroid carcinoma

      ea0092ps2-17-04
    • 18F-DOPA-PET/ct in medullary thyroid cancer patients with biochemical incomplete response

      ea0092ps2-17-05
    • Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: A retrospective and observational study

      ea0092ps2-17-06
    • Correlation of three thyroglobulin assays in the management of differentiated thyroid cancer (DTC) patients

      ea0092ps2-17-07
    • Characteristics of incidental pappillary thyroid microcarcinomas detected by various nuclear medicine imaging techniques

      ea0092ps2-17-08
    • Clinical application of grading system in sporadic medullary thyroid carcinoma patients

      ea0092ps2-17-09
  • Treatment 1
  • • Role of radiofrequency ablation in the treatment of symptomatic distant metastasis of thyroid cancer

      ea0092ps2-18-01
    • Abstract unavailable

      ea0092ps2-18-02
    • A systematic drug repurposing approach for anaplastic thyroid cancer

      ea0092ps2-18-03
    • Comparative effectiveness of selpercatinib vs standard treatment in patients with medullary thyroid cancer: An interpatient analysis from libretto-001

      ea0092ps2-18-04
    • The first experience of laser interstitial thermotherapy in the treatment of patients with nodular goiter and cytology tbsrtc iv

      ea0092ps2-18-05
    • Prognostic model of the rate and risk of papillary thyroid cancer local metastases based on preoperative clinical and ulrasonic predictors

      ea0092ps2-18-06
    • Role of preoperative serum calcitonin and carcinoembryonic antigen in predicting surgical extent of lateral lymph node metastasis in medullary thyroid carcinoma: a multicenter study in korea

      ea0092ps2-18-07
    • Clinical practice guidelines for radiofrequency ablation of benign thyroid nodules and malignant thyroid cancers: A systematic review

      ea0092ps2-18-08
    • Evaluation of real-world efficacy in lenvatinib and pembrolizumab treated poorly (PDTC) and anaplastic (ATC) thyroid cancer patients

      ea0092ps2-18-09
  • Thyroid Hormone Transport & Metabolism Basic
  • • Types 2 and 3 deiodinase are induced in blood cells of critical ill patients: Implications to nonthyroidal illness syndrome pathophysiology

      ea0092ps2-19-01
    • PResence of MCT8 and OATP1C1 in mouse endothelial cells is required for normal brain development and function

      ea0092ps2-19-02
    • Thyroid hormone metabolite 3-iodothyronamine (T1AM) as an effective repressor of microglia-mediated neuroinflammation

      ea0092ps2-19-03
    • Repositioning of cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase

      ea0092ps2-19-04
    • Characterization of epcam in thyroid cancer biology by three-dimensional spheroids in vitro model

      ea0092ps2-19-05
    • DIO2 and dehal1 are common targets of MIR-146B and PAX8 shaping a regulatory circuit that modulates the differentiated phenotype of papillary thyroid carcinomas

      ea0092ps2-19-06
    • Absence of MCT8 and OATP1C1 in mouse oligodendroglia cells results in delayed myelination

      ea0092ps2-19-07
    • Thyroglobulin detection in extracellular vesicles isolated from human plasma

      ea0092ps2-19-08
  • Thyroid hormone receptors basic
  • • Thyroid hormone receptor beta expression changes have a limited impact on non-alcoholic steatohepatitis progression

      ea0092ps2-20-01
    • Central actions of thyroid hormone: The role of the zona incerta

      ea0092ps2-20-02
    • Epigenome-wide association study reveals cpg sites associated with thyroid function and regulatory effects on KLF9

      ea0092ps2-20-03
    • Staying cool in the heat - the role of thyroid hormone receptor alpha in thermoregulation

      ea0092ps2-20-04
    • Human resistance to thyroid hormone beta operates via a mechanism requiring receptor binding to DNA

      ea0092ps2-20-05
    • A cardiac developmental defect prevents thyroid hormone-induced tachycardia in the syndrome of resistance to thyroid hormone alpha

      ea0092ps2-20-06
    • Local thyroid hormone action in T cells - shaping T cell immunity

      ea0092ps2-20-07
    • Immunophenotyping of mice with mutated thyroid hormone receptor alpha or beta

      ea0092ps2-20-08
    • The relevance of histidine 175 in thyroid hormone receptor alpha 1 for co-repressor binding revealed by a family carrying a H175R variant

      ea0092ps2-20-09
  • Hypothyroidism
  • • Patients' persistent symptoms during therapy for hypothyroidism: results from the "thesis"* collaboration. (*treatment of hypothyroidism in europe by specialists, an international survey)

      ea0092ps3-21-01
    • Use of t3-containing treatments for hypothyroidism: results from the "thesis"* collaboration (*treatment of hypothyroidism in europe by specialists: an international survey)

      ea0092ps3-21-02
    • Tryptophan metabolism via kynurenine pathway in young women with hypothyroidism

      ea0092ps3-21-03
    • Autoimmune thyroid disease and hypothyroidism in patients with iron deficiency

      ea0092ps3-21-04
    • The hypothyroid mothers' newborn repercussions in a semi-intensive care unit

      ea0092ps3-21-05
    • Liquid Levothyroxine (L-T4; vs. Tablet L-T4) mantains more stable tsh levels in hypothyroid patients

      ea0092ps3-21-06
    • Assessing the risk of atrial fibrillation in hypothyroid women prescribed with liothyronine: A retrospective cohort study

      ea0092ps3-21-07
    • Consumptive hypothyroidism in a patient with metastatic melanoma: A case report on a new association

      ea0092ps3-21-08
    • Efficacy of oral liquid l-thyroxine (L-T4) in controlling hypothyroidism in patients submitted to total thyroidectomy

      ea0092ps3-21-09
  • Nodules 2
  • • Radiofrequency ablation of benign thyroid nodules: Value of the anterolateral hydrodissection technique

      ea0092ps3-22-01
    • Abstract unavailable

      ea0092ps3-22-02
    • Determinants of hypothyroidism post-radioactive therapy in toxic adenomas and toxic multinodular goiter: A multicenter cohort study

      ea0092ps3-22-03
    • Abstract unavailable

      ea0092ps3-22-04
    • Prevalence and incidence of thyroid nodule and its risk factors; a population-based prospective cohort study in iodine-sufficient area

      ea0092ps3-22-05
    • Italian guideline on the management of benign non-hyperfunctioning thyroid nodule causing compressive symptoms

      ea0092ps3-22-06
    • A pharmacoeconomic analysis from italian guidelines for the management of non-hyperfunctioning, bening thyroid nodules

      ea0092ps3-22-07
    • Natural course of benign thyroid nodular disease in a borderline iodine-sufficient area: 10-year retrospective follow-up data from a tertiary center

      ea0092ps3-22-08
    • Percutaneous ethanol sclerotherapy for the treatment of benign cystic thyroid nodules: A 5 year-experience at a tertiary care hospital

      ea0092ps3-22-09
  • Pregnancy
  • • TSH elevation before or after a pregnancy according to unidentified maternal thyroid function and thyroid autoantibody status in the early pregnancy: A study of 13,664 danish pregnant women

      ea0092ps3-23-01
    • B cells from anti-thyroid antibody positive, infertile women show hyper-reactivity to BCR stimulation

      ea0092ps3-23-02
    • Prevalence of postpartum worsening of graves' orbitopathy in relation to thyroid dysfunction in patients with graves' disease in japan

      ea0092ps3-23-03
    • Physical development, neuropsychological health and quality of life in a group of adult subjects with congenital hypothyroidism early treated with levothyroxine after newborn screening

      ea0092ps3-23-04
    • Iodine nutritional status and related thyroid function in pregnancy: A results of a prospective study conducted in a large group of women

      ea0092ps3-23-05
    • Iodine nutrition in italian pregnant women: preliminary results of a multicenter study

      ea0092ps3-23-06
    • Effect of selenium supplementation on carbohydrate metabolism in hungarian patients with and without pregnancy

      ea0092ps3-23-07
    • The thyroid status of patients with gestationnal diabetes

      ea0092ps3-23-08
    • Clinical impact of the thyroid hormone measure and the reference intervals in critically ill pregnant women

      ea0092ps3-23-09
  • Thyroid Eye Disease
  • • Simultaneous graves' orbitopathy and ocular myasthenia gravis in a patient with type 1 diabetes mellitus

      ea0092ps3-24-01
    • Long-Term outcome of moderate-to-severe, active graves' orbitopathy following treatment with sirolimus (Ramamycin): results in a case series

      ea0092ps3-24-02
    • Teprotumumab efficacy in european and us study sites participating in the phase 2, optic (Phase 3) and optic-x pivotal trials

      ea0092ps3-24-03
    • Rituximab treatment in patients with graves' orbitopathy who are non-responsive to intravenous glucocorticoids is not better than IV glucocorticoids alone

      ea0092ps3-24-04
    • Teprotumumab for the treatment of recalcitrant thyroid eye disease

      ea0092ps3-24-05
    • Perceptions reported by graves' disease euthyroid patients with ophthalmopathy: A qualitative study

      ea0092ps3-24-06
    • Incidence and risk factors for graves' orbitopathy in patients who underwent anti-inframmatory and immunosuppressive treatment during medical treatment for graves' disease

      ea0092ps3-24-07
    • Changes in therapeutic response, ocular manifestations of graves' orbitopathy and quality of life during the first year after orbital radiotherapy

      ea0092ps3-24-08
    • Clinical conditions related to the short, medium and long term clinical outcome of moderate/severe graves' ophthalmopathy to parenteral glucocorticoids: a retrospective study

      ea0092ps3-24-09
  • Case Reports 2
  • • Uncommon findings in a thyroid nodule: A case report of osseous metaplasia in a benign thyroid lesion

      ea0092ps3-25-01
    • A rare case of autoimmune polyglandular syndrome type 2

      ea0092ps3-25-02
    • Report of a case with new onset of thyroid eye disease following viral vector SARS-COV-2 Vaccine

      ea0092ps3-25-03
    • Dupilumab-related graves disease: A case report

      ea0092ps3-25-04
    • A rare case of euthyroid graves ophthalmopathy with negative trabs titers

      ea0092ps3-25-05
    • DIfferent presentations of thyroid dermopathy

      ea0092ps3-25-06
    • A case report of graves' disease induced by IFN-[beta]-1a therapy

      ea0092ps3-25-07
    • Resistance to thyroid hormone in the absence of thyroid hormone receptor mutation: A case report

      ea0092ps3-25-08
    • Autoimmune hypothyroidism associated with pseudohypoparathyroidism

      ea0092ps3-25-09
  • Thyroid hormone diagnostics 2
  • • Predictors of bethesda i category in thyroid fine needle aspiration cytology

      ea0092ps3-26-01
    • Diverse clinical and laboratory phenotypes associated with heterozygous PAX8 mutations

      ea0092ps3-26-02
    • Association between ultrasonographic findings and thyroid function in autoimmune diffuse thyroid disease in children and adolescents

      ea0092ps3-26-03
    • Diagnostic performance of 18F-choline PET/CT for detection of hyperfunctioning parathyroid glands in patients with primary hyperparathyroidism: a single-center experience

      ea0092ps3-26-04
    • Radiomics analysis of thyroid ultrasound in relation to the radioactive iodine therapy-related sialadenitis

      ea0092ps3-26-05
    • Does hypoechogenicity, as a single variable in decision of FNA, offer similar sensitivity and specificity as the elaborate tirads in the 10-20 mm range of thyroid nodules for cancer detection?

      ea0092ps3-26-06
    • Ultrasound and cytological evaluation of PET-CT positive incidental thyroid lesions

      ea0092ps3-26-07
    • Assessment of thyroid stiffness in beta thalassemia patients by using shear-wave ultrasound elastography

      ea0092ps3-26-08
    • Thyroid antibodies and early response to treatment in graves' disease

      ea0092ps3-26-09
  • Thyroid Cancer clinical 3
  • • Clinicopathological features of intrathyroidal thymic carcinoma: A single center experiences

      ea0092ps3-27-01
    • Central (N1A) and latero-cervical (N1B) lymph nodes metastases in sporadic medullary thyroid carcinoma patients: clinical impact on disease specific and recurrence free survival

      ea0092ps3-27-02
    • A large series of patients with anaplastic thyroid cancer managed in a tertiary referral center

      ea0092ps3-27-03
    • Comparison of patient-reported outcomes between active surveillance and immediate surgery for low-risk papillary thyroid carcinoma: A longitudinal study with one-year follow-up

      ea0092ps3-27-04
    • Changes in clinical presentation of paediatric differentiated thyroid cancer (DTC) treated in one centre over 40 years

      ea0092ps3-27-05
    • Skeletal related events in differentiated thyroid carcinoma with bone metastasis: A bicentric study

      ea0092ps3-27-06
    • Clinical significance of de novo appearance of anti-thyroglobulin antibodies in patients of differentiated thyroid cancer with radioiodine therapy

      ea0092ps3-27-07
    • Lymph nodes metastases from papillary thyroid microcarcinoma negatively impact on outcome

      ea0092ps3-27-08
    • Finding the right balance in optimizing post-operative suppression therapy after papillary thyroid carcinoma - a case report

      ea0092ps3-27-09
  • Translational 2
  • • Study on the role of podoplanin in papillary thyroid carcinoma using rna sequencing

      ea0092ps3-28-01
    • Hypothesizing a role of ret hyperactivation on weight control in patients with type 2A multiple endocrine neoplasia (MEN2A)

      ea0092ps3-28-02
    • Molecular analysis of multiple foci of sporadic medullary thyroid carcinoma suggests that they are intrathyroidal metastases from the same primary tumor

      ea0092ps3-28-03
    • Effect of pazopanib in anaplastic thyroid cancer in primary culture

      ea0092ps3-28-04
    • Pediatric thyroid nodules with germline and somatic DICER1 variants

      ea0092ps3-28-05
    • Next-generation-sequencing on fine needle aspirates in neck recurrence of thyroid cancers

      ea0092ps3-28-06
    • Expression of focal adhesion kinase microrna regulators is related to dedifferentiation in thyroid neoplasia spectrum

      ea0092ps3-28-07
    • Understanding the putative role OF ACE2, TMPRSS2 and furin proteins on thyroid neoplastic transformation

      ea0092ps3-28-08
    • Detection of ras mutations leads to non-aggressive treatment of thyroid tumors

      ea0092ps3-28-09
  • Treatment 2
  • • Impact of local treatments in progressive, advanced, radioiodine-refractory thyroid cancer

      ea0092ps3-29-01
    • Efficacy of ethanol ablation in the long-term local control of recurrent neck nodal metastases occurring after bilateral thyroidectomy, extensive nodal resection and postoperative radioiodine therapy in adult patients presenting with node-positive UICC/AJCC ptnm stage i papillary thyroid carcinoma.

      ea0092ps3-29-02
    • TKIS for advanced thyroid cancer increase tsh levels in thyroidectomized patients: A meta-analysis

      ea0092ps3-29-03
    • Effectiveness of lenvatinib in progressive metastatic radioiodine refractory well differentiated and poorly differentiated thyroid carcinoma

      ea0092ps3-29-04
    • Tailored mortality risk in stage I-II DTC patients by integrating ata stratification and response to initial therapy

      ea0092ps3-29-05
    • Dabrafenib and trametinib treatment in patients with braf-mutated advanced thyroid cancer

      ea0092ps3-29-06
    • Hypocalcemia occurrence in patients with advanced thyroid cancer during tyrosine-kinase inhibitor treatment

      ea0092ps3-29-07
    • Efficacy of tyrosine-kinase-inhibition in thyroid cancer - A retrospective, single-centre, real-world evaluation

      ea0092ps3-29-08
    • Effects of neoadjuvant chemoradiotherapy on unresectable anaplastic thyroid carcinoma

      ea0092ps3-29-09
  • Thyroid Physiology in Periphery & Development Basic
  • • Developing an animal-free testing battery for thyroid hormone related developmental neurotoxicity

      ea0092ps3-30-01
    • Combined triiodothyronine and preconditioning improves cardiac diastolic dysfunction in ex vivo rat hearts subjected to normothermic perfusion: a new method for donor heart preservation

      ea0092ps3-30-02
    • The human thyroid-derived cl-huthyrecs cell line expresses the thyrotropin (TSH) receptor and thyroglobulin but lacks other essential characteristics of thyroid follicular cells

      ea0092ps3-30-03
    • Thyroid hormone treatment counteracts pathological alterations in diabetic nephropathy and diabetic cardiomyopathy

      ea0092ps3-30-04
    • Acute T3 administration reduces myocardial infarct size

      ea0092ps3-30-05
    • Development and characterization of a simple human thyroid organoid in vitro model for thyroid metabolism investigation

      ea0092ps3-30-06
    • Combined effect of a perinatal exposure to a thyroid hormone signaling disrupting chemical (TBBPA) and western diet on hypothalamic transcriptome

      ea0092ps3-30-07
    • Identification of FOXE1 promoter variants in families with cleft palate, struma ovarii and thyroid lesions

      ea0092ps3-30-08
    • Desiccated thyroid powder: old-new therapy of hypothyroidism and quantitative analysis of triiodothyronine and thyroxine in the pharmceutical preparation

      ea0092ps3-30-09